Merrion Pharmaceuticals Plc - Product Pipeline Review - 2013

Aug 31, 2013 - Global Markets Direct - 25 pages - USD $1,500
Abstract Table of Contents Request Details Related
Global Market Direct's pharmaceuticals report, "Merrion Pharmaceuticals Plc - Product Pipeline Review - 2013" provides data on the Merrion Pharmaceuticals Plc's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Merrion Pharmaceuticals Plc's corporate website, SEC filings, investor presentations and featured press releases, both from Merrion Pharmaceuticals Plc and industry-specific third party sources, put together by Global Markets Direct's team.

Scope of this Report:
  • Merrion Pharmaceuticals Plc - Brief Merrion Pharmaceuticals Plc overview including business description, key information and facts, and its locations and subsidiaries.
  • Review of current pipeline of Merrion Pharmaceuticals Plc human therapeutic division.
  • Overview of pipeline therapeutics across various therapy areas.
  • Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
  • Product profiles for late stage and clinical stage products of Merrion Pharmaceuticals Plc with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
  • Recent updates of the Merrion Pharmaceuticals Plc's pipeline in the last quarter.
  • Key discontinued and dormant projects.
  • Latest news and deals relating to the products.
Reasons to Get this Report:
  • Evaluate Merrion Pharmaceuticals Plc's strategic position with total access to detailed information on its product pipeline.
  • Assess the growth potential of Merrion Pharmaceuticals Plc in its therapy areas of focus.
  • Identify new drug targets and therapeutic classes in the Merrion Pharmaceuticals Plc's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
  • Exploit collaboration and partnership opportunities with Merrion Pharmaceuticals Plc.
  • Avoid Intellectual Property Rights related issues.
  • Explore the dormant and discontinued projects of Merrion Pharmaceuticals Plc and identify potential opportunities in those areas.

Order This Report
LICENSE: Single-User
DELIVERY: By Email - 1 Business Day

Once you’ve found the right report, click ‘order now’ and complete the checkout process using any major credit card, check or wire/bank transfer.

Need multi-user or enterprise license pricing? Contact us for a custom quote!
MC, Visa, AMEX, Diners, Discovery, JCB

The Fast Market Research Advantage
Only the Best
All of our research is sourced from the most trusted and established global analysts and consultancies

Client Focused
From start-ups to multinationals, we focus on providing the right research to our diverse client base

Shop Securely
Our US-based customer service team and eCommerce systems adhere to highest data security standards

Industry-leading Customer Support
Individualized assistance from our expert staff is never more than an email or phone call away

About the Publisher
Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information.